AVIR vs COST · $353.7M cap vs P/E 55, rev $275.24B
Atea Pharmaceuticals Inc (AVIR) versus Costco Wholesale Corp (COST) — a side-by-side from cached financials, not a winner call.
Atea Pharmaceuticals Inc (AVIR) is a biotechnology company listed on US.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
AVIR does not have a complete income-statement cache yet.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
AVIR currently screens at market cap $353.7M. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Not investment advice. Open the AVIR and COST stock pages for the full models.
Not investment advice.